ID   PKHA1_HUMAN             Reviewed;         404 AA.
AC   Q9HB21; B3KQ55; D3DRE2; Q9BVK0;
DT   29-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   29-MAR-2004, sequence version 2.
DT   07-APR-2021, entry version 161.
DE   RecName: Full=Pleckstrin homology domain-containing family A member 1;
DE            Short=PH domain-containing family A member 1;
DE   AltName: Full=Tandem PH domain-containing protein 1;
DE            Short=TAPP-1;
GN   Name=PLEKHA1; Synonyms=TAPP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, MUTAGENESIS OF ARG-28 AND
RP   ARG-211, TISSUE SPECIFICITY, AND VARIANT ALA-320.
RX   PubMed=11001876; DOI=10.1042/0264-6021:3510019;
RA   Dowler S.J., Currie R.A., Campbell D.G., Deak M., Kular G., Downes C.P.,
RA   Alessi D.R.;
RT   "Identification of pleckstrin-homology-domain-containing proteins with
RT   novel phosphoinositide-binding specificities.";
RL   Biochem. J. 351:19-31(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ALA-320.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH MPDZ, AND SUBCELLULAR LOCATION.
RX   PubMed=11802782; DOI=10.1042/0264-6021:3610525;
RA   Kimber W.A., Trinkle-Mulcahy L., Cheung P.C.F., Deak M., Marsden L.J.,
RA   Kieloch A., Watt S., Javier R.T., Gray A., Downes C.P., Lucocq J.M.,
RA   Alessi D.R.;
RT   "Evidence that the tandem-pleckstrin-homology-domain-containing protein
RT   TAPP1 interacts with Ptd(3,4)P2 and the multi-PDZ-domain-containing protein
RT   MUPP1 in vivo.";
RL   Biochem. J. 361:525-536(2002).
RN   [7]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12101241; DOI=10.1128/mcb.22.15.5479-5491.2002;
RA   Marshall A.J., Krahn A.K., Ma K., Duronio V., Hou S.;
RT   "TAPP1 and TAPP2 are targets of phosphatidylinositol 3-kinase signaling in
RT   B cells: sustained plasma membrane recruitment triggered by the B-cell
RT   antigen receptor.";
RL   Mol. Cell. Biol. 22:5479-5491(2002).
RN   [8]
RP   INTERACTION WITH PTPN13, AND FUNCTION.
RX   PubMed=14516276; DOI=10.1042/bj20031154;
RA   Kimber W.A., Deak M., Prescott A.R., Alessi D.R.;
RT   "Interaction of the protein tyrosine phosphatase PTPL1 with the
RT   PtdIns(3,4)P2-binding adaptor protein TAPP1.";
RL   Biochem. J. 376:525-535(2003).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-362, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-332, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 190-292, FUNCTION, AND MUTAGENESIS
RP   OF ALA-203; VAL-204; MET-205 AND ASN-207.
RX   PubMed=11513726; DOI=10.1042/0264-6021:3580287;
RA   Thomas C.C., Dowler S.J., Deak M., Alessi D.R., van Aalten D.M.F.;
RT   "Crystal structure of the phosphatidylinositol 3,4-bisphosphate-binding
RT   pleckstrin homology (PH) domain of tandem PH-domain-containing protein 1
RT   (TAPP1): molecular basis of lipid specificity.";
RL   Biochem. J. 358:287-294(2001).
CC   -!- FUNCTION: Binds specifically to phosphatidylinositol 3,4-diphosphate
CC       (PtdIns3,4P2), but not to other phosphoinositides. May recruit other
CC       proteins to the plasma membrane. {ECO:0000269|PubMed:11001876,
CC       ECO:0000269|PubMed:11513726, ECO:0000269|PubMed:14516276}.
CC   -!- SUBUNIT: Interacts with MPDZ and PTPN13. {ECO:0000269|PubMed:11802782,
CC       ECO:0000269|PubMed:14516276}.
CC   -!- INTERACTION:
CC       Q9HB21; O75970: MPDZ; NbExp=6; IntAct=EBI-2652984, EBI-821405;
CC       Q9HB21; Q9P0V3: SH3BP4; NbExp=2; IntAct=EBI-2652984, EBI-1049513;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11802782,
CC       ECO:0000269|PubMed:12101241}. Cell membrane
CC       {ECO:0000269|PubMed:11802782, ECO:0000269|PubMed:12101241}; Peripheral
CC       membrane protein. Nucleus {ECO:0000269|PubMed:11802782,
CC       ECO:0000269|PubMed:12101241}. Note=Locates to the plasma membrane after
CC       treatments that stimulate the production of PtdIns3,4P2.
CC       {ECO:0000269|PubMed:11802782}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9HB21-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HB21-2; Sequence=VSP_043091;
CC   -!- TISSUE SPECIFICITY: Highly expressed in skeletal muscle, thymus,
CC       pancreas, placenta and lung. Detected at low levels in brain, heart,
CC       peripheral blood leukocytes, testis, ovary, spinal cord, thyroid,
CC       kidney, liver, small intestine and colon. {ECO:0000269|PubMed:11001876,
CC       ECO:0000269|PubMed:12101241}.
CC   -!- DOMAIN: Binds to membranes enriched in PtdIns3,4P2 via the C-terminal
CC       PH domain.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF286160; AAG15197.1; -; mRNA.
DR   EMBL; AK057463; BAG51917.1; -; mRNA.
DR   EMBL; BX664700; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX842242; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471066; EAW49315.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49316.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49318.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49319.1; -; Genomic_DNA.
DR   EMBL; BC001136; AAH01136.1; -; mRNA.
DR   EMBL; BC042458; AAH42458.1; -; mRNA.
DR   CCDS; CCDS55730.1; -. [Q9HB21-2]
DR   CCDS; CCDS7629.1; -. [Q9HB21-1]
DR   RefSeq; NP_001001974.1; NM_001001974.2. [Q9HB21-1]
DR   RefSeq; NP_001182537.1; NM_001195608.1. [Q9HB21-2]
DR   RefSeq; NP_001317107.1; NM_001330178.1.
DR   RefSeq; NP_067635.2; NM_021622.4. [Q9HB21-1]
DR   RefSeq; XP_005270073.1; XM_005270016.1.
DR   RefSeq; XP_005270078.1; XM_005270021.4.
DR   RefSeq; XP_016871969.1; XM_017016480.1. [Q9HB21-1]
DR   RefSeq; XP_016871970.1; XM_017016481.1. [Q9HB21-1]
DR   RefSeq; XP_016871971.1; XM_017016482.1. [Q9HB21-1]
DR   RefSeq; XP_016871979.1; XM_017016490.1. [Q9HB21-2]
DR   RefSeq; XP_016871980.1; XM_017016491.1.
DR   PDB; 1EAZ; X-ray; 1.40 A; A=182-303.
DR   PDBsum; 1EAZ; -.
DR   SMR; Q9HB21; -.
DR   BioGRID; 121880; 30.
DR   IntAct; Q9HB21; 16.
DR   MINT; Q9HB21; -.
DR   STRING; 9606.ENSP00000357986; -.
DR   ChEMBL; CHEMBL3763005; -.
DR   DrugBank; DB04272; Citric acid.
DR   GlyGen; Q9HB21; 2 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; Q9HB21; -.
DR   PhosphoSitePlus; Q9HB21; -.
DR   BioMuta; PLEKHA1; -.
DR   DMDM; 48474647; -.
DR   EPD; Q9HB21; -.
DR   jPOST; Q9HB21; -.
DR   MassIVE; Q9HB21; -.
DR   MaxQB; Q9HB21; -.
DR   PaxDb; Q9HB21; -.
DR   PeptideAtlas; Q9HB21; -.
DR   PRIDE; Q9HB21; -.
DR   ProteomicsDB; 81474; -. [Q9HB21-1]
DR   ProteomicsDB; 81475; -. [Q9HB21-2]
DR   Antibodypedia; 1178; 169 antibodies.
DR   DNASU; 59338; -.
DR   Ensembl; ENST00000368988; ENSP00000357984; ENSG00000107679. [Q9HB21-2]
DR   Ensembl; ENST00000368990; ENSP00000357986; ENSG00000107679. [Q9HB21-1]
DR   Ensembl; ENST00000392799; ENSP00000376547; ENSG00000107679. [Q9HB21-1]
DR   Ensembl; ENST00000433307; ENSP00000394416; ENSG00000107679. [Q9HB21-1]
DR   GeneID; 59338; -.
DR   KEGG; hsa:59338; -.
DR   UCSC; uc001lge.3; human. [Q9HB21-1]
DR   CTD; 59338; -.
DR   DisGeNET; 59338; -.
DR   GeneCards; PLEKHA1; -.
DR   HGNC; HGNC:14335; PLEKHA1.
DR   HPA; ENSG00000107679; Low tissue specificity.
DR   MIM; 607772; gene.
DR   neXtProt; NX_Q9HB21; -.
DR   OpenTargets; ENSG00000107679; -.
DR   PharmGKB; PA33401; -.
DR   VEuPathDB; HostDB:ENSG00000107679.14; -.
DR   eggNOG; ENOG502QT2K; Eukaryota.
DR   GeneTree; ENSGT00940000155157; -.
DR   HOGENOM; CLU_055135_2_0_1; -.
DR   InParanoid; Q9HB21; -.
DR   OMA; IPWRSED; -.
DR   OrthoDB; 1513983at2759; -.
DR   PhylomeDB; Q9HB21; -.
DR   TreeFam; TF329516; -.
DR   PathwayCommons; Q9HB21; -.
DR   Reactome; R-HSA-1660499; Synthesis of PIPs at the plasma membrane.
DR   BioGRID-ORCS; 59338; 5 hits in 992 CRISPR screens.
DR   ChiTaRS; PLEKHA1; human.
DR   EvolutionaryTrace; Q9HB21; -.
DR   GeneWiki; PLEKHA1; -.
DR   GenomeRNAi; 59338; -.
DR   Pharos; Q9HB21; Tbio.
DR   PRO; PR:Q9HB21; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q9HB21; protein.
DR   Bgee; ENSG00000107679; Expressed in chorionic villus and 237 other tissues.
DR   ExpressionAtlas; Q9HB21; baseline and differential.
DR   Genevisible; Q9HB21; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0032587; C:ruffle membrane; IDA:UniProtKB.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:UniProtKB.
DR   GO; GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding; IDA:UniProtKB.
DR   GO; GO:0008209; P:androgen metabolic process; IEA:Ensembl.
DR   GO; GO:0050853; P:B cell receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IDA:UniProtKB.
DR   GO; GO:0045184; P:establishment of protein localization; IDA:UniProtKB.
DR   GO; GO:0008210; P:estrogen metabolic process; IEA:Ensembl.
DR   GO; GO:0060325; P:face morphogenesis; IEA:Ensembl.
DR   GO; GO:0033327; P:Leydig cell differentiation; IEA:Ensembl.
DR   GO; GO:0001553; P:luteinization; IEA:Ensembl.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0051898; P:negative regulation of protein kinase B signaling; IMP:UniProtKB.
DR   GO; GO:0014065; P:phosphatidylinositol 3-kinase signaling; IDA:UniProtKB.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome.
DR   GO; GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0009791; P:post-embryonic development; IEA:Ensembl.
DR   GO; GO:0060021; P:roof of mouth development; IEA:Ensembl.
DR   GO; GO:0031529; P:ruffle organization; IDA:UniProtKB.
DR   GO; GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   Gene3D; 2.30.29.30; -; 2.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   Pfam; PF00169; PH; 2.
DR   SMART; SM00233; PH; 2.
DR   PROSITE; PS50003; PH_DOMAIN; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Cytoplasm;
KW   Lipid-binding; Membrane; Nucleus; Phosphoprotein; Reference proteome;
KW   Repeat.
FT   CHAIN           1..404
FT                   /note="Pleckstrin homology domain-containing family A
FT                   member 1"
FT                   /id="PRO_0000053873"
FT   DOMAIN          7..112
FT                   /note="PH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          191..289
FT                   /note="PH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   MOD_RES         332
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         362
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   VAR_SEQ         301..404
FT                   /note="EHPPGPSESKHAFRPTNAATATSHSTASRSNSLVSTFTMEKRGFYESLAKVK
FT                   PGNFKVQTVSPREPASKVTEQALLRPQSKNGPQEKDCDLVDLDDASLPVSDV -> MRQ
FT                   ARRLSNPCIQRYTSRAGECSTYVGSHANVPS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043091"
FT   VARIANT         320
FT                   /note="T -> A (in dbSNP:rs1045216)"
FT                   /evidence="ECO:0000269|PubMed:11001876, ECO:0000269|Ref.4"
FT                   /id="VAR_024562"
FT   MUTAGEN         28
FT                   /note="R->L: No effect on phosphatidylinositide binding."
FT                   /evidence="ECO:0000269|PubMed:11001876"
FT   MUTAGEN         203..205
FT                   /note="AVM->GGG: Abolishes phosphatidylinositide binding."
FT   MUTAGEN         203..205
FT                   /note="AVM->GLV: Binds both PtdIns3,4P2 and PtdIns3,4,5P3."
FT   MUTAGEN         203..204
FT                   /note="AV->GG: Binds both PtdIns3,4P2 and PtdIns3,4,5P3."
FT   MUTAGEN         203
FT                   /note="A->G: Binds both PtdIns3,4P2 and PtdIns3,4,5P3."
FT                   /evidence="ECO:0000269|PubMed:11513726"
FT   MUTAGEN         204
FT                   /note="V->L: No effect."
FT                   /evidence="ECO:0000269|PubMed:11513726"
FT   MUTAGEN         205
FT                   /note="M->V: No effect."
FT                   /evidence="ECO:0000269|PubMed:11513726"
FT   MUTAGEN         207
FT                   /note="N->T: No effect."
FT                   /evidence="ECO:0000269|PubMed:11513726"
FT   MUTAGEN         211
FT                   /note="R->L: Abolishes phosphatidylinositide binding."
FT                   /evidence="ECO:0000269|PubMed:11001876"
FT   STRAND          193..201
FT                   /evidence="ECO:0007744|PDB:1EAZ"
FT   TURN            203..205
FT                   /evidence="ECO:0007744|PDB:1EAZ"
FT   STRAND          208..215
FT                   /evidence="ECO:0007744|PDB:1EAZ"
FT   STRAND          217..225
FT                   /evidence="ECO:0007744|PDB:1EAZ"
FT   STRAND          232..236
FT                   /evidence="ECO:0007744|PDB:1EAZ"
FT   HELIX           237..239
FT                   /evidence="ECO:0007744|PDB:1EAZ"
FT   STRAND          242..245
FT                   /evidence="ECO:0007744|PDB:1EAZ"
FT   HELIX           249..252
FT                   /evidence="ECO:0007744|PDB:1EAZ"
FT   STRAND          255..261
FT                   /evidence="ECO:0007744|PDB:1EAZ"
FT   STRAND          266..270
FT                   /evidence="ECO:0007744|PDB:1EAZ"
FT   HELIX           274..290
FT                   /evidence="ECO:0007744|PDB:1EAZ"
SQ   SEQUENCE   404 AA;  45553 MW;  6855CD58E1A80F8A CRC64;
     MPYVDRQNRI CGFLDIEENE NSGKFLRRYF ILDTREDSFV WYMDNPQNLP SGSSRVGAIK
     LTYISKVSDA TKLRPKAEFC FVMNAGMRKY FLQANDQQDL VEWVNVLNKA IKITVPKQSD
     SQPNSDNLSR HGECGKKQVS YRTDIVGGVP IITPTQKEEV NECGESIDRN NLKRSQSHLP
     YFTPKPPQDS AVIKAGYCVK QGAVMKNWKR RYFQLDENTI GYFKSELEKE PLRVIPLKEV
     HKVQECKQSD IMMRDNLFEI VTTSRTFYVQ ADSPEEMHSW IKAVSGAIVA QRGPGRSASS
     EHPPGPSESK HAFRPTNAAT ATSHSTASRS NSLVSTFTME KRGFYESLAK VKPGNFKVQT
     VSPREPASKV TEQALLRPQS KNGPQEKDCD LVDLDDASLP VSDV
//
